Metastatic Bone Pain Palliation using (177)Lu-Ethylenediaminetetramethylene Phosphonic Acid.

Alavi, Mehrosadat; Omidvari, Shapour; Mehdizadeh, Alireza; Jalilian, Amir R; Bahrami-Samani, Ali

Alavi, Mehrosadat; Omidvari, Shapour; Mehdizadeh, Alireza; Jalilian, Amir R; Bahrami-Samani, Ali.

Afiliación

Alavi M; Department of Nuclear Medicine, Shiraz University of Medical Sciences, Shiraz, Tehran, Iran.
Omidvari S; Department of Radiotherapy, Shiraz University of Medical Sciences, Shiraz, Tehran, Iran.
Mehdizadeh A; Department of Medical Physics and Engineering, Shiraz University of Medical Sciences, Shiraz, Tehran, Iran.
Jalilian AR; Department of Radiopharmaceutical Research and Development Laboratory, Nuclear Science and Technology Research Institute, Tehran, Iran.
Bahrami-Samani A; Department of Radiopharmaceutical Research and Development Laboratory, Nuclear Science and Technology Research Institute, Tehran, Iran.

World J Nucl Med ; 14(2): 109-15, 2015.

Article en En | MEDLINE | ID: mdl-26097421

Palabras clave

177Lu-ethylenediaminetetramethylene phosphonic acid; bone pain palliation; metastasis; nuclear medicine; targeted radionuclide therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: World J Nucl Med Año: 2015 Tipo del documento: Article País de afiliación: Irán